Nanoemulsions Industry Research Report 2025

Summary

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.
Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.

According to APO Research, The global Nanoemulsions market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nanoemulsions is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Nanoemulsions include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical, GlaxoSmithKline, Novartis AG, Sanofi and B. Braun Melsungen. etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nanoemulsions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoemulsions.
The Nanoemulsions market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanoemulsions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nanoemulsions Segment by Company

Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen
Nanoemulsions Segment by Type

Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
Nanoemulsions Segment by Application

Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
Nanoemulsions Segment by Application

Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
Nanoemulsions Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanoemulsions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanoemulsions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanoemulsions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanoemulsions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Nanoemulsions by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Steroids
2.2.3 Anesthetics
2.2.4 NSAIDs
2.2.5 Immunosuppressant
2.2.6 Antiretroviral
2.2.7 Antimicrobials
2.2.8 Vasodilators
2.2.9 Others
2.3 Nanoemulsions by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Pharmaceutical Industrial
2.3.3 Cosmetic Industrial
2.3.4 Food Industrial
2.3.5 Others
2.4 Assumptions and Limitations
3 Nanoemulsions Breakdown Data by Type
3.1 Global Nanoemulsions Historic Market Size by Type (2020-2025)
3.2 Global Nanoemulsions Forecasted Market Size by Type (2026-2031)
4 Nanoemulsions Breakdown Data by Application
4.1 Global Nanoemulsions Historic Market Size by Application (2020-2025)
4.2 Global Nanoemulsions Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Nanoemulsions Market Perspective (2020-2031)
5.2 Global Nanoemulsions Growth Trends by Region
5.2.1 Global Nanoemulsions Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Nanoemulsions Historic Market Size by Region (2020-2025)
5.2.3 Nanoemulsions Forecasted Market Size by Region (2026-2031)
5.3 Nanoemulsions Market Dynamics
5.3.1 Nanoemulsions Industry Trends
5.3.2 Nanoemulsions Market Drivers
5.3.3 Nanoemulsions Market Challenges
5.3.4 Nanoemulsions Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Nanoemulsions Players by Revenue
6.1.1 Global Top Nanoemulsions Players by Revenue (2020-2025)
6.1.2 Global Nanoemulsions Revenue Market Share by Players (2020-2025)
6.2 Global Nanoemulsions Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Nanoemulsions Head Office and Area Served
6.4 Global Nanoemulsions Players, Product Type & Application
6.5 Global Nanoemulsions Manufacturers Established Date
6.6 Global Nanoemulsions Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Nanoemulsions Market Size (2020-2031)
7.2 North America Nanoemulsions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Nanoemulsions Market Size by Country (2020-2025)
7.4 North America Nanoemulsions Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Nanoemulsions Market Size (2020-2031)
8.2 Europe Nanoemulsions Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Nanoemulsions Market Size by Country (2020-2025)
8.4 Europe Nanoemulsions Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Nanoemulsions Market Size (2020-2031)
9.2 Asia-Pacific Nanoemulsions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Nanoemulsions Market Size by Country (2020-2025)
9.4 Asia-Pacific Nanoemulsions Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Nanoemulsions Market Size (2020-2031)
10.2 South America Nanoemulsions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Nanoemulsions Market Size by Country (2020-2025)
10.4 South America Nanoemulsions Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Nanoemulsions Market Size (2020-2031)
11.2 Middle East & Africa Nanoemulsions Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Nanoemulsions Market Size by Country (2020-2025)
11.4 Middle East & Africa Nanoemulsions Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Allergan plc
12.1.1 Allergan plc Company Information
12.1.2 Allergan plc Business Overview
12.1.3 Allergan plc Revenue in Nanoemulsions Business (2020-2025)
12.1.4 Allergan plc Nanoemulsions Product Portfolio
12.1.5 Allergan plc Recent Developments
12.2 AbbVie Inc.
12.2.1 AbbVie Inc. Company Information
12.2.2 AbbVie Inc. Business Overview
12.2.3 AbbVie Inc. Revenue in Nanoemulsions Business (2020-2025)
12.2.4 AbbVie Inc. Nanoemulsions Product Portfolio
12.2.5 AbbVie Inc. Recent Developments
12.3 AstraZeneca Inc.
12.3.1 AstraZeneca Inc. Company Information
12.3.2 AstraZeneca Inc. Business Overview
12.3.3 AstraZeneca Inc. Revenue in Nanoemulsions Business (2020-2025)
12.3.4 AstraZeneca Inc. Nanoemulsions Product Portfolio
12.3.5 AstraZeneca Inc. Recent Developments
12.4 Fresenius Kabi AG
12.4.1 Fresenius Kabi AG Company Information
12.4.2 Fresenius Kabi AG Business Overview
12.4.3 Fresenius Kabi AG Revenue in Nanoemulsions Business (2020-2025)
12.4.4 Fresenius Kabi AG Nanoemulsions Product Portfolio
12.4.5 Fresenius Kabi AG Recent Developments
12.5 Kaken Pharmaceutical
12.5.1 Kaken Pharmaceutical Company Information
12.5.2 Kaken Pharmaceutical Business Overview
12.5.3 Kaken Pharmaceutical Revenue in Nanoemulsions Business (2020-2025)
12.5.4 Kaken Pharmaceutical Nanoemulsions Product Portfolio
12.5.5 Kaken Pharmaceutical Recent Developments
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Revenue in Nanoemulsions Business (2020-2025)
12.6.4 GlaxoSmithKline Nanoemulsions Product Portfolio
12.6.5 GlaxoSmithKline Recent Developments
12.7 Novartis AG
12.7.1 Novartis AG Company Information
12.7.2 Novartis AG Business Overview
12.7.3 Novartis AG Revenue in Nanoemulsions Business (2020-2025)
12.7.4 Novartis AG Nanoemulsions Product Portfolio
12.7.5 Novartis AG Recent Developments
12.8 Sanofi
12.8.1 Sanofi Company Information
12.8.2 Sanofi Business Overview
12.8.3 Sanofi Revenue in Nanoemulsions Business (2020-2025)
12.8.4 Sanofi Nanoemulsions Product Portfolio
12.8.5 Sanofi Recent Developments
12.9 B. Braun Melsungen
12.9.1 B. Braun Melsungen Company Information
12.9.2 B. Braun Melsungen Business Overview
12.9.3 B. Braun Melsungen Revenue in Nanoemulsions Business (2020-2025)
12.9.4 B. Braun Melsungen Nanoemulsions Product Portfolio
12.9.5 B. Braun Melsungen Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings